Jeffrey Swenson
Family Medicine · Rupert, IDNPI 1376531004
Payments from drug & device makers
Across 114 payments — averaging $18.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$458
- AstraZeneca$415
- Amgen$168
- Novo Nordisk$153
- Boehringer Ingelheim$149
- Exact Sciences$132
- plus $690 from 17 others
What the payments were for
- Food & beverage$2,165100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 20 | $458 |
| AstraZeneca | 13 | $415 |
| Amgen | 12 | $168 |
| Novo Nordisk | 10 | $153 |
| Boehringer Ingelheim | 9 | $149 |
| Exact Sciences | 8 | $132 |
| Lilly USA, LLC | 8 | $111 |
| Astellas Pharma US Inc | 3 | $89 |
| Bayer | 5 | $82 |
| Boston Scientific | 4 | $67 |
| Johnson & Johnson(2 entities) | 4 | $47 |
| Dexcom, Inc. | 2 | $37 |
| Radius Health, Inc. | 2 | $36 |
| Merck | 2 | $35 |
| Novartis | 2 | $34 |
| Inspire Medical Systems, Inc. | 1 | $33 |
| E.r. Squibb & Sons, L.L.C. | 2 | $27 |
| Pfizer | 2 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| GSK | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Esperion Therapeutics, Inc. | 1 | $13 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,165 in reported general payments places this provider in the 85th percentile of 803 family medicine providers in Idaho.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 76 | $78,182 |
| OzempicSemaglutide | 65 | $62,321 |
| TrulicityDulaglutide | 35 | $45,858 |
| EliquisApixaban | 15 | $24,596 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 29 | $22,214 |
| XareltoRivaroxaban | 17 | $14,848 |
| Risperdal ConstaRisperidone Microspheres | 11 | $12,949 |
| LinzessLinaclotide | 17 | $8,808 |
| Breo ElliptaFluticasone/Vilanterol | 20 | $7,930 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $6,268 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 53 | $4,662 |
| Gabapentin | 200 | $4,072 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 15 | $3,969 |
| Levothyroxine Sodium | 371 | $3,928 |
| Pantoprazole Sodium | 271 | $3,927 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $111 | $124,040111 claims |
| Novo NordiskOzempic | $153 | $62,32165 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $14 | $30,14449 claims |
| Johnson & JohnsonXarelto, Risperdal Consta | $47 | $27,79728 claims |
| PfizerEliquis | $25 | $24,59615 claims |
| AbbVieLinzess | $458 | $8,80817 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 803 family medicine providers in Idaho.
Other family medicine in Rupert
- Mark TurnerMeridian$40.5M
- David ButukMeridian$15.2M
- Gary SoucieBlackfoot$5.8M
- Brock McConneheyBoise$4.5M
- William LaitinenMiddleton$1.1M
- Diane McConneheyBoise$681K
- Flint PackerIdaho Falls$587K
- Paul BeckettBlackfoot$344K
- Elaine DavidsonMeridian$303K
- Kenneth CongerSandpoint$266K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.